New malaria vaccine shows great promise in early clinical trials

Malaria is the leading deadly disease on the continent, killing more than 400,000 people a year. A potential malaria vaccine has proven to be about 77 per cent effective in early clinical trials, suggesting it could be a possible breakthrough in the fight against the disease. Professor Halidou Tinto, Principal Investigator of the vaccine trial spoke with CNBC Africa for more.

Mon Apr 26 2021 | 14:52:23 GMT+0000 (Coordinated Universal Time)


Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.